Consequently, Teva is licensed to launch a generic version of Victoza as of 22 December 2023. Under certain circumstances Teva could launch a generic version of Victoza earlier,
The post Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva appeared first on Pharmaceutical Business review.